Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 156

1.

Just Another Trauma Case in the Ophthalmic Emergency Room.

Bacon MM.

Insight. 2016 Spring;41(2):22-3. No abstract available.

PMID:
27209687
2.

How can acute space be better used?

Bacon M.

Health Estate. 2015 Sep;69(8):45-9. No abstract available.

PMID:
26548127
3.

Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.

Lheureux S, Karakasis K, Harter P, Scott C, Bacon M, Bryce J, Le Fur N, Pujade-Lauraine E, Oza AM.

Gynecol Oncol. 2016 Jan;140(1):90-4. doi: 10.1016/j.ygyno.2015.10.010. Epub 2015 Oct 22.

PMID:
26475959
4.

Low energy--bridging the Great Divide.

Bacon M.

Health Estate. 2015 Feb;69(2):33-7.

PMID:
26268016
5.

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators.

Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23.

6.

The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup.

Gaffney DK, Suneja G, Ryu SY, McCormick M, Plante M, Mileshkin L, Small W Jr, Bacon M, Stuart G, Kitchener H.

Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):506-8. doi: 10.1016/j.ijrobp.2015.02.054. No abstract available.

7.

Large animal and primate models of spinal cord injury for the testing of novel therapies.

Kwon BK, Streijger F, Hill CE, Anderson AJ, Bacon M, Beattie MS, Blesch A, Bradbury EJ, Brown A, Bresnahan JC, Case CC, Colburn RW, David S, Fawcett JW, Ferguson AR, Fischer I, Floyd CL, Gensel JC, Houle JD, Jakeman LB, Jeffery ND, Jones LA, Kleitman N, Kocsis J, Lu P, Magnuson DS, Marsala M, Moore SW, Mothe AJ, Oudega M, Plant GW, Rabchevsky AS, Schwab JM, Silver J, Steward O, Xu XM, Guest JD, Tetzlaff W.

Exp Neurol. 2015 Jul;269:154-68. doi: 10.1016/j.expneurol.2015.04.008. Epub 2015 Apr 19.

PMID:
25902036
8.

The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries.

Suneja G, Bacon M, Small W Jr, Ryu SY, Kitchener HC, Gaffney DK.

Front Oncol. 2015 Feb 19;5:14. doi: 10.3389/fonc.2015.00014. eCollection 2015.

9.

Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment.

Despierre E, Yesilyurt BT, Lambrechts S, Johnson N, Verheijen R, van der Burg M, Casado A, Rustin G, Berns E, Leunen K, Amant F, Moerman P, Lambrechts D, Vergote I; EORTC GCG and EORTC GCG Translational Research Group.

Int J Gynecol Cancer. 2014 Mar;24(3):468-77. doi: 10.1097/IGC.0000000000000089.

PMID:
24557434
10.

Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.

Cortes CP, Wehbe FH, McGowan CC, Shepherd BE, Duda SN, Jenkins CA, Gonzalez E, Carriquiry G, Schechter M, Padgett D, Cesar C, Madero JS, Pape JW, Masys DR, Sterling TR; Caribbean, Central American, South American Network for HIV Research of the International Epidemiologic Databases to Evaluate AIDS.

PLoS One. 2013 Sep 16;8(9):e74057. doi: 10.1371/journal.pone.0074057. eCollection 2013.

11.

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy.

Greimel E, Kristensen GB, van der Burg ME, Coronado P, Rustin G, del Rio AS, Reed NS, Nordal RR, Coens C, Vergote I; European Organization for Research and Treatment of Cancer - Gynaecological Cancer Group and NCIC Clinical Trials Group.

Gynecol Oncol. 2013 Nov;131(2):437-44. doi: 10.1016/j.ygyno.2013.08.014. Epub 2013 Aug 27.

PMID:
23994107
12.

The current state-of-the-art of spinal cord imaging: applications.

Wheeler-Kingshott CA, Stroman PW, Schwab JM, Bacon M, Bosma R, Brooks J, Cadotte DW, Carlstedt T, Ciccarelli O, Cohen-Adad J, Curt A, Evangelou N, Fehlings MG, Filippi M, Kelley BJ, Kollias S, Mackay A, Porro CA, Smith S, Strittmatter SM, Summers P, Thompson AJ, Tracey I.

Neuroimage. 2014 Jan 1;84:1082-93. doi: 10.1016/j.neuroimage.2013.07.014. Epub 2013 Jul 14. Review.

13.

Incidence of female urethral diverticulum: a population-based analysis and literature review.

El-Nashar SA, Bacon MM, Kim-Fine S, Weaver AL, Gebhart JB, Klingele CJ.

Int Urogynecol J. 2014 Jan;25(1):73-9. doi: 10.1007/s00192-013-2155-2. Epub 2013 Jul 16. Review.

14.

Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?

Kwon BK, Soril LJ, Bacon M, Beattie MS, Blesch A, Bresnahan JC, Bunge MB, Dunlop SA, Fehlings MG, Ferguson AR, Hill CE, Karimi-Abdolrezaee S, Lu P, McDonald JW, Müller HW, Oudega M, Rosenzweig ES, Reier PJ, Silver J, Sykova E, Xu XM, Guest JD, Tetzlaff W.

Exp Neurol. 2013 Oct;248:30-44. doi: 10.1016/j.expneurol.2013.05.012. Epub 2013 May 29. Erratum in: Exp Neurol. 2013 Oct;248:299-300.

PMID:
23727091
15.

The current state-of-the-art of spinal cord imaging: methods.

Stroman PW, Wheeler-Kingshott C, Bacon M, Schwab JM, Bosma R, Brooks J, Cadotte D, Carlstedt T, Ciccarelli O, Cohen-Adad J, Curt A, Evangelou N, Fehlings MG, Filippi M, Kelley BJ, Kollias S, Mackay A, Porro CA, Smith S, Strittmatter SM, Summers P, Tracey I.

Neuroimage. 2014 Jan 1;84:1070-81. doi: 10.1016/j.neuroimage.2013.04.124. Epub 2013 May 14. Review.

16.

The contractual governance of drug users in treatment.

Bacon M, Seddon T.

Int J Drug Policy. 2013 Sep;24(5):379-84. doi: 10.1016/j.drugpo.2012.12.008. Epub 2013 Jan 23.

17.

Metacontrast masking is processed before grapheme-color synesthesia.

Bacon MP, Bridgeman B, Ramachandran VS.

Atten Percept Psychophys. 2013 Jan;75(1):5-9. doi: 10.3758/s13414-012-0401-1.

PMID:
23188733
18.

Bias towards dementia: are hip fracture trials excluding too many patients? A systematic review.

Hebert-Davies J, Laflamme GY, Rouleau D; HEALTH and FAITH investigators.

Injury. 2012 Dec;43(12):1978-84. doi: 10.1016/j.injury.2012.08.061. Epub 2012 Sep 19. Review.

PMID:
22999009
19.

Voluntary medical male circumcision: an HIV prevention priority for PEPFAR.

Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, Bailey R, Cherutich P, Curran K, Dickson K, Farley T, Hankins C, Hatzold K, Justman J, Mwandi Z, Nkinsi L, Ridzon R, Ryan C, Bock N.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S88-95. doi: 10.1097/QAI.0b013e31825cac4e. Review.

20.

Effects of enhanced bolus flavors on oropharyngeal swallow in patients treated for head and neck cancer.

Pauloski BR, Logemann JA, Rademaker AW, Lundy D, Sullivan PA, Newman LA, Lazarus C, Bacon M.

Head Neck. 2013 Aug;35(8):1124-31. doi: 10.1002/hed.23086. Epub 2012 Aug 21.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk